Waleed Ghanima

Oslo, Norway

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 211 publications

Rilzabrutinib for persistent or chronic immune thrombocytopenia (ITP): a Bruton tyrosine kinase inhibitor that can target multiple pathophysiological pathways.

Rilzabrutinib for persistent or chronic immune thrombocytopenia (ITP): a Bruton tyrosine kinase inhibitor that can target multiple pathophysiological pathways.

Journal: Expert review of hematology

Published: May 10, 2026

Interleukin-17-associated inflammation in non-responders and B-cell remodeling after daratumumab in refractory immune thrombocytopenia.

Interleukin-17-associated inflammation in non-responders and B-cell remodeling after daratumumab in refractory immune thrombocytopenia.

Journal: Haematologica

Published: April 09, 2026

Efficacy and Safety of Subcutaneous Efgartigimod PH20 in Adults With Primary Immune Thrombocytopenia (ADVANCE SC): A Multicenter, Randomized, Double-Blinded, Placebo-Controlled, Phase 3 Trial.

Efficacy and Safety of Subcutaneous Efgartigimod PH20 in Adults With Primary Immune Thrombocytopenia (ADVANCE SC): A Multicenter, Randomized, Double-Blinded, Placebo-Controlled, Phase 3 Trial.

Journal: American journal of hematology

Published: March 09, 2026

The impact of symptom duration on D-dimer: results from the Venous Thrombosis Registry in Østfold Hospital.

The impact of symptom duration on D-dimer: results from the Venous Thrombosis Registry in Østfold Hospital.

Journal: Research and practice in thrombosis and haemostasis

Published: March 01, 2026

MicroRNAs as potential architects of immune dysregulation and megakaryocytic failure in immune thrombocytopenia.

MicroRNAs as potential architects of immune dysregulation and megakaryocytic failure in immune thrombocytopenia.

Journal: British journal of haematology

Published: January 21, 2026

Bleeding and Recurrence in Patients with Venous Thromboembolism with Changing Anticoagulant Treatment Patterns: Findings from the TROLL Registry.

Bleeding and Recurrence in Patients with Venous Thromboembolism with Changing Anticoagulant Treatment Patterns: Findings from the TROLL Registry.

Journal: TH open : companion journal to thrombosis and haemostasis

Published: January 18, 2026

Exploring the Burden on Patients Living With and Receiving Treatment for Immune Thrombocytopenia (ITP): Patient and Physician Perceptions From the ITP World Impact Survey (I-WISh) 2.0.

Exploring the Burden on Patients Living With and Receiving Treatment for Immune Thrombocytopenia (ITP): Patient and Physician Perceptions From the ITP World Impact Survey (I-WISh) 2.0.

Journal: American journal of hematology

Published: December 18, 2025

Diagnostic management of suspected acute pulmonary embolism in the postpartum period.

Diagnostic management of suspected acute pulmonary embolism in the postpartum period.

Journal: Journal of thrombosis and haemostasis : JTH

Published: December 11, 2025

Ianalumab plus Eltrombopag in Immune Thrombocytopenia.

Ianalumab plus Eltrombopag in Immune Thrombocytopenia.

Journal: The New England journal of medicine

Published: December 09, 2025

Treatment strategies, bleeding, long-term recurrence and mortality in abdominal vein thrombosis: Findings from the TROLL registry.

Treatment strategies, bleeding, long-term recurrence and mortality in abdominal vein thrombosis: Findings from the TROLL registry.

Journal: Thrombosis research

Published: December 01, 2025

Anti-CD38 therapy in immune thrombocytopenia (ITP).

Anti-CD38 therapy in immune thrombocytopenia (ITP).

Journal: British journal of haematology

Published: November 24, 2025

Thrombosis in immune thrombocytopenia.

Thrombosis in immune thrombocytopenia.

Journal: British journal of haematology

Published: November 16, 2025

Showing 1-12 of 211

Last Updated: 09/26/2026